News tagged with astrazeneca
Faulty gene connected to ovarian cancer risk
In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...
Cancer
Aug 09, 2011 |
not rated yet |
0
|
Indian drug giant Cipla slashes cancer drug prices
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
Medications
May 04, 2012 |
4.9 / 5 (9) |
0
Findings support link between hsCRP, macular degeneration
(HealthDay)—Pooled results from five cohorts confirm that high levels of high-sensitivity C-reactive protein (hsCRP) correlate with increased future risk of age-related macular degeneration (AMD), according ...
Ophthalmology
Feb 08, 2013 |
not rated yet |
0
Redefinition of positive CT result for lung cancer explored
(HealthDay)—Increasing the threshold for defining a positive result in computed tomography (CT) screening for lung cancer could reduce the need for further work-up but must be weighed against the potential ...
Cancer
Feb 20, 2013 |
not rated yet |
0
Accelerating drug development
All human clinical trials of new treatments begin with phase I, where drugs are tested in isolation to confirm their safety. Yet most effective cancer treatments use a combination of drugs, so-called 'multi-agent' ...
Medications
Mar 08, 2013 |
5 / 5 (2) |
0
Pharma giants open up drug patents in new collaboration
Pharmaceutical giants and the UN intellectual property agency launched Wednesday a collaboration to share certain patented drug information with public organisations.
Medications
Oct 26, 2011 |
5 / 5 (1) |
2
Dapagliflozin aids glycemic control in type 2 diabetes
(HealthDay) -- For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control, stabilized insulin dosing, and weight reductions, according ...
Diabetes
Mar 20, 2012 |
not rated yet |
0
FDA approves first 4-in-1 flu vaccine
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.
Medications
Feb 29, 2012 |
5 / 5 (1) |
0
SABCS: Extending tamoxifen to 10 years beneficial in breast CA
(HealthDay)—For women with estrogen receptor (ER)-positive early breast cancer, continuing tamoxifen to 10 years correlates with reduced risk of recurrence and lower breast cancer-specific and overall mortality, ...
Cancer
Dec 05, 2012 |
not rated yet |
0
AstraZeneca settles legal dispute with Watson (Update)
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca has settled a patent dispute with Watson Laboratories, Inc., removing a threat against its top-selling cholesterol-control drug, Crestor.
Medications
Mar 25, 2013 |
not rated yet |
0
AstraZeneca reorg to cut 1,600 jobs in US, UK
(AP)—Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization.
Medications
Mar 18, 2013 |
not rated yet |
0
AstaZeneca in patent warning as net profit falls
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit on Thursday.
Other
Jan 31, 2013 |
not rated yet |
0
AstraZeneca to cut 2,300 jobs in business overhaul
(AP)—Struggling drug company AstraZeneca outlined a major restructuring of its business on Thursday, including some 2,300 job cuts worldwide as it overhauls its research operations.
Medications
Mar 21, 2013 |
not rated yet |
0
Drug approved to treat high blood pressure
(HealthDay) -- The high blood pressure drug Toprol XL has been combined with a low-dose diuretic to form Dutoprol (metoprolol succinate extended release/hyrdrochlorothiazide), which has been approved by the U.S. Food and ...
Medications
Apr 13, 2012 |
not rated yet |
0
Ticagrelor: Considerable added benefit for specific patients
Since the start of 2011, the active ingredient ticagrelor can be prescribed in Germany in addition to acetylsalicylic acid (ASA) to avoid blood clots in patients with acute ischaemia of the cardiac muscle. The German Institute ...
Medical research
Oct 11, 2011 |
not rated yet |
0
AstraZeneca
AstraZeneca plc (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993. The Company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
For more information about AstraZeneca, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
